ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.47398_47402dup (p.Ser15802fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV003226067 SCV003922170 likely pathogenic Early-onset myopathy with fatal cardiomyopathy 2023-05-02 criteria provided, single submitter curation The heterozygous p.Ser15802ArgfsTer10 variant in TTN was identified by our study, in the compound heterozygous state with a variant of uncertain significance (NC_000002.12:g.178720984A>C), in one individual with Salih myopathy. Familial exome analysis revealed that this variant was in trans with a variant of uncertain significance (NC_000002.12:g.178720984A>C). The p.Ser15802ArgfsTer10 variant in TTN has not been previously reported in individuals with Salih myopathy. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 15802 and leads to a premature termination codon 10 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the TTN gene is an established disease mechanism in autosomal recessive Salih myopathy. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive Salih myopathy. ACMG/AMP Criteria applied: PVS1, PM2_Supporting (Richards 2015).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.